Logo-ddj
Submitted: 30 Apr 2023
Revision: 17 Jun 2023
Accepted: 18 Jun 2023
ePublished: 14 Oct 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Dis Diagn. 2024;13(1): 13-17.
doi: 10.34172/ddj.518
  Abstract View: 68
  PDF Download: 58

Original Article

The Prevalence of Pulmonary Hypertension in Beta-Thalassemia Patients in Hormozgan Province: A Cross-sectional Study

Atefeh Ghareghani 1 ORCID logo, Sedighe Pirdadi 2 ORCID logo, Marzieh Nikparvar 1* ORCID logo, Shideh Rafati 3 ORCID logo, Hanie Bagheri 4 ORCID logo, Mohammad Hamed Ersi 4,5 ORCID logo

1 Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
2 Student Research Committee, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
3 Social Determinants in Health Promotion Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
4 Clinical Research Development Center of Shahid Mohammadi Hospital, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
5 Evidence-Based Medicine Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
*Corresponding Author: Marzieh Nikparvar, Email: nikparvarheart1@gmail.com

Abstract

Background: Pulmonary hypertension (PH) is associated with an increased risk of cardiac failure among asymptomatic patients with beta-thalassemia. This study aimed to determine the prevalence of PH and associated risk factors in patients with beta-thalassemia major (TM) and beta-thalassemia intermedia (TI) in Hormozgan province, Iran.

Materials and Methods: Eighty-nine patients, including 65 TM and 24 TI, were enrolled in this cross-sectional study. The data regarding the gender, age, history of splenectomy, and type of chelating therapy were collected, and then hematocrit, hemoglobin (Hb), and serum ferritin levels were determined. Doppler echocardiography was performed for patients, and tricuspid regurgitation jet velocity (TRV)≥2.5 m/s was used to screen PH. Eventually, the data were analyzed using SPSS.

Results: The prevalence of TRV≥2.5 m/s was 21.3% in all patients, indicating that it was not significantly different between patients with TM (21.8%) and TI (20.8%). There was a significant association between the prevalence of PH and the male gender. Based on the results, TRV≥2.5 m/s was observed in both children and adults. No significant association was detected between Hb, serum ferritin levels, and splenectomy with PH prevalence.

Conclusion: The findings revealed that PH is common in both children and adult patients with TM and TI in our population and should be considered to choose the optimal treatment of patients with TM and TI.

First Name
Last Name
Email Address
Comments
Security code


Abstract View: 68

Your browser does not support the canvas element.


PDF Download: 58

Your browser does not support the canvas element.